S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AGIO Agios Pharmaceuticals Inc

32.19

0.35 (1.10%)

04 Jan 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Agios Pharmaceuticals Charts.

Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Agios Pharmaceuticals Charts.

Agios Pharmaceuticals Inc News

Form 144 - Report of proposed sale of securities
Saturday 4 January 2025 (2 days ago) • Edgar (US Regulatory)

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
Friday 3 January 2025 (2 days ago) • GlobeNewswire Inc.

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
Wednesday 18 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 14 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat
Monday 9 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

More Agios Pharmaceuticals Inc News Articles

Commonwealth Bank Of Aus...

Westpac Banking

Invesco QQQ Trust Series 1

Australia And New Zealan...

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions